My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Regeneron Pharmaceuticals (NQ:REGN)

803.17 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Regeneron Pharmaceuticals

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

49 50 Next >

The Greatest 7 Blue-Chip Stocks to Buy for Your Portfolio ↗

April 20, 2023

With so many rumblings in the equities space, investors may be best served taking on the top blue-chip stocks to buy.

Via InvestorPlace

Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 5 Years ↗

April 18, 2023

Via Benzinga

Regeneron Pharmaceuticals Unusual Options Activity ↗

April 12, 2023

Via Benzinga

MAIA Biotechnology Touts Positive Data From Healthy Volunteer Study Of Potential Lung Cancer Candidate ↗

April 11, 2023

Via Benzinga

Investing $1,000 In These 2 Top Stocks Would Be a Great Move ↗

April 09, 2023

Both have beaten the market over the past year.

Via The Motley Fool

2 Top Growth Stocks That Could Soar This Spring ↗

April 06, 2023

Exciting news on the way for both of these companies could send their stock prices screaming higher.

Via The Motley Fool

Regeneron Pharmaceuticals Unusual Options Activity For April 05 ↗

April 05, 2023

Via Benzinga

$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today ↗

April 03, 2023

Via Benzinga

JP Morgan Maintains Overweight Rating for Regeneron Pharmaceuticals: Here's What You Need To Know ↗

March 31, 2023

Via Benzinga

Regeneron Pharmaceuticals Unusual Options Activity For March 28 ↗

March 28, 2023

Via Benzinga

Large Cap Biopharmaceuticals Q1 2023: In This Bullish Run Biotech Lags ↗

April 03, 2023

It was very difficult to make money in Q1 trading healthcare or biotech ETFs because of the sharp rally in other sectors. Nonetheless, there were two big winners.

Via Talk Markets

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 03, 2023

Via Benzinga

NVIDIA To Rally Around 18%? Here Are 10 Other Analyst Forecasts For Friday ↗

March 31, 2023

Benchmark cut the price target for CuriosityStream Inc. (NASDAQ: CURI) from $8 to $4. Benchmark analyst Daniel Kurnos maintained a Buy rating. CuriosityStream shares dropped 22.5% to $1.24 in...

Via Benzinga

Is This Pharma Duo on the Brink of Another Billion-Dollar Opportunity? ↗

March 30, 2023

Sanofi and Regeneron's top-selling drug could soon be approved to treat yet another disease.

Via The Motley Fool

Analyst Ratings for Regeneron Pharmaceuticals ↗

March 27, 2023

Via Benzinga

Baird Maintains Neutral Rating for Regeneron Pharmaceuticals: Here's What You Need To Know ↗

March 24, 2023

Via Benzinga

Why Shares of Regeneron Are Rising Thursday ↗

March 23, 2023

Regeneron released positive phase 3 trial results for its therapy Dupixent.

Via The Motley Fool

(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest ↗

March 23, 2023

Via Benzinga

Regeneron Pharmaceuticals, Hess And 1 Of World's Biggest Bank: CNBC's 'Final Trades' ↗

March 28, 2023

On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management said she is sticking with Regeneron Pharmaceuticals, Inc.

Via Benzinga

UNITY Biotechnology's Wet AMD Candidate Flunks On Non-Inferiority Threshold Compared To Regeneron's Drug ↗

March 27, 2023

UNITY Biotechnology Inc (NASDAQ: UBX) announced results from Part A of the Phase 2 ENVISION study of UBX1325 in patients with wet age-related macular degeneration (AMD) who were not achieving optimum...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 27, 2023 ↗

March 27, 2023

Via Benzinga

Pinterest To Rally Over 27%? Here Are 10 Other Analyst Forecasts For Monday ↗

March 27, 2023

UBS cut the price target for DISH Network Corporation (NASDAQ: DISH) from $27 to $10. UBS analyst John Hodulik downgraded the stock from Buy to Neutral. DISH Network shares fell 2.1% to $8.57 in...

Via Benzinga

Could This Label Expansion Be a Growth Catalyst for Sanofi Stock? ↗

March 25, 2023

Sanofi and Regeneron's mega-blockbuster drug could soon be approved in the U.S. for yet another indication.

Via The Motley Fool

Wall Street Has High Hopes for These 2 Nasdaq Stocks ↗

March 24, 2023

Even in choppy markets, there are smart investments you can make.

Via The Motley Fool

Stock Market Split As Fed Hikes Rates, Banks Keep Tumbling; Nvidia, On Holding In Focus: Weekly Review ↗

March 24, 2023

The major indexes showed volatile, divergent action.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2023 ↗

March 24, 2023

Via Benzinga

Regeneron Pharmaceuticals Analysts React To Drug Trial Results: Why Whales Are Diving In ↗

March 24, 2023

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) announced the Phase 3 trial of Dupixent (dupilumab), developed with Sanofi (NASDAQ: SNY), for uncontrolled chronic obstructive pulmonary disease (COPD) met...

Via Benzinga

Regeneron Pharmaceuticals Options Traders Betting On Stock Falling This Much By April Expiration ↗

March 24, 2023

Sanofi (NASDAQ: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares surged on Thursday after the companies announced primary and all key secondary endpoints were met in a Phase 3 trial...

Via Benzinga

US Stocks On Track For Weak Start Friday Amid Renewed Banking Concerns And Contagion Fears ↗

March 24, 2023

Renewed concerns about the banking system appear to weigh on stocks, as the major index futures point to a sharply lower opening on Friday.

Via Benzinga

Why Are Stocks Up Today? ↗

March 23, 2023

Stocks are up today as investors react to the latest news from the Federal Reverse concerning a new interest rate increase.

Via InvestorPlace

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

49 50 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.